Vaidya KS, Mitten MJ, Zelaya-Lazo AL, Oleksijew A, et al. Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR. J Neurooncol 2021 Jan 30. pii: 10.1007/s11060-021-03703.
PMID: 33517558